Sign In
10 Aug 2021 11:35
Ap24
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
Date of dealing | 9 August 2021 |
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
370,561(New Borrow)* 571,520 | N/A 10.7800 GBP | N/A 10.7550 GBP |
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
112,823 | 10.7800 GBP | 10.7000 GBP |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swap | Opening a Long Position
Opening a Short Position
| 502 2,745 860 25,559 7,468 23,981 1,179 16,782
1,774 333,333 19,717 474 2,443 13,700 354 | 10.7298 GBP 10.7622 GBP 10.7628 GBP 10.7684 GBP 10.7699 GBP 10.7700 GBP 10.7748 GBP 10.7794 GBP
10.7601 GBP 10.7630 GBP 10.7699 GBP 10.7701 GBP 10.7705 GBP 10.7751 GBP 10.7802 GBP |
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
|
|
|
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition
or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Date of disclosure | 10 August 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |
Follow the stocks
